# PeptideScanner evidence objects: Gonadorelin

Every published version of the records placed with Gonadorelin, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json. Selected public evidence only; not medical advice.

- Objects: 22
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct00000325-gonadorelin-v1"></a>

## ClinicalTrials.gov record NCT00000325

> PeptideScanner retained ClinicalTrials.gov record NCT00000325 at 2026-11-16T17:31:07.936Z. Its registry update date was 2017-01-12, and PeptideScanner's reviewed identity mapping was gonadorelin.

- Evidence object: `story:clinicaltrials-gov-nct00000325-gonadorelin:v1`
- Evidence domain: Clinical trials
- Date in source: 2017-01-12
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00000325-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct00000325-gonadorelin-v1
- Content SHA-256: `afb9ee37a90c4ac866a6fd8db68b7a7dca160523c8a56398d6a609626bfb1f81`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00000325 ([`ctg-observation-nct00000325-2017-01-12-53c68a67e4ad`](#source-ctg-observation-nct00000325-2017-01-12-53c68a67e4ad))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00000325 at 2026-11-16T17:31:07.936Z. Its registry update date was 2017-01-12, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct00000325-2017-01-12-53c68a67e4ad`](#source-ctg-observation-nct00000325-2017-01-12-53c68a67e4ad))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00000325 at 2026-11-16T17:31:07.936Z. Its registry update date was 2017-01-12, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct00000325-2017-01-12-53c68a67e4ad`](#source-ctg-observation-nct00000325-2017-01-12-53c68a67e4ad))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00000325-2017-01-12-53c68a67e4ad`](#source-ctg-observation-nct00000325-2017-01-12-53c68a67e4ad))

### Sources

<a id="source-ctg-observation-nct00000325-2017-01-12-53c68a67e4ad"></a>
- **ClinicalTrials.gov record NCT00000325 · retained source version 2017-01-12:53c68a67e4ad8be3c7b1b749a7b51c02cbe63c350b051b1fe10474c5fe8e847e** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00000325) (`ctg-observation-nct00000325-2017-01-12-53c68a67e4ad`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00000325." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct00000325-gonadorelin-v1 SHA-256: afb9ee37a90c4ac866a6fd8db68b7a7dca160523c8a56398d6a609626bfb1f81.

---

<a id="clinicaltrials-gov-nct00296465-gonadorelin-v1"></a>

## ClinicalTrials.gov record NCT00296465

> PeptideScanner retained ClinicalTrials.gov record NCT00296465 at 2026-11-16T17:31:07.936Z. Its registry update date was 2011-05-19, and PeptideScanner's reviewed identity mapping was gonadorelin.

- Evidence object: `story:clinicaltrials-gov-nct00296465-gonadorelin:v1`
- Evidence domain: Clinical trials
- Date in source: 2011-05-19
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00296465-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct00296465-gonadorelin-v1
- Content SHA-256: `0588caa933b76b09c9c7ade3797130f37d1232c13bbc50ac8ade3b6b47804d1b`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00296465 ([`ctg-observation-nct00296465-2011-05-19-abe9c01bf224`](#source-ctg-observation-nct00296465-2011-05-19-abe9c01bf224))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00296465 at 2026-11-16T17:31:07.936Z. Its registry update date was 2011-05-19, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct00296465-2011-05-19-abe9c01bf224`](#source-ctg-observation-nct00296465-2011-05-19-abe9c01bf224))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00296465 at 2026-11-16T17:31:07.936Z. Its registry update date was 2011-05-19, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct00296465-2011-05-19-abe9c01bf224`](#source-ctg-observation-nct00296465-2011-05-19-abe9c01bf224))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00296465-2011-05-19-abe9c01bf224`](#source-ctg-observation-nct00296465-2011-05-19-abe9c01bf224))

### Sources

<a id="source-ctg-observation-nct00296465-2011-05-19-abe9c01bf224"></a>
- **ClinicalTrials.gov record NCT00296465 · retained source version 2011-05-19:abe9c01bf22462f566e12b6e9768ce2255fdc0572ee868d440107aa6853476c8** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00296465) (`ctg-observation-nct00296465-2011-05-19-abe9c01bf224`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00296465." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct00296465-gonadorelin-v1 SHA-256: 0588caa933b76b09c9c7ade3797130f37d1232c13bbc50ac8ade3b6b47804d1b.

---

<a id="clinicaltrials-gov-nct01976728-gonadorelin-v1"></a>

## ClinicalTrials.gov record NCT01976728

> PeptideScanner retained ClinicalTrials.gov record NCT01976728 at 2026-11-16T17:31:07.936Z. Its registry update date was 2021-03-03, and PeptideScanner's reviewed identity mapping was gonadorelin.

- Evidence object: `story:clinicaltrials-gov-nct01976728-gonadorelin:v1`
- Evidence domain: Clinical trials
- Date in source: 2021-03-03
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01976728-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct01976728-gonadorelin-v1
- Content SHA-256: `3e6894766e9aa62402f7140b55bbe2568a0fbbd13453bc2a4889cefd7a0ab1b2`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01976728 ([`ctg-observation-nct01976728-2021-03-03-d99afd737a5f`](#source-ctg-observation-nct01976728-2021-03-03-d99afd737a5f))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01976728 at 2026-11-16T17:31:07.936Z. Its registry update date was 2021-03-03, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct01976728-2021-03-03-d99afd737a5f`](#source-ctg-observation-nct01976728-2021-03-03-d99afd737a5f))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01976728 at 2026-11-16T17:31:07.936Z. Its registry update date was 2021-03-03, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct01976728-2021-03-03-d99afd737a5f`](#source-ctg-observation-nct01976728-2021-03-03-d99afd737a5f))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01976728-2021-03-03-d99afd737a5f`](#source-ctg-observation-nct01976728-2021-03-03-d99afd737a5f))

### Sources

<a id="source-ctg-observation-nct01976728-2021-03-03-d99afd737a5f"></a>
- **ClinicalTrials.gov record NCT01976728 · retained source version 2021-03-03:d99afd737a5f65533bfeac9053da5a01b9c8003ef03ade819bb765f20af47bf3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01976728) (`ctg-observation-nct01976728-2021-03-03-d99afd737a5f`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01976728." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct01976728-gonadorelin-v1 SHA-256: 3e6894766e9aa62402f7140b55bbe2568a0fbbd13453bc2a4889cefd7a0ab1b2.

---

<a id="clinicaltrials-gov-nct02653092-gonadorelin-v1"></a>

## ClinicalTrials.gov record NCT02653092

> PeptideScanner retained ClinicalTrials.gov record NCT02653092 at 2026-11-16T17:31:07.936Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was gonadorelin.

- Evidence object: `story:clinicaltrials-gov-nct02653092-gonadorelin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-02
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02653092-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct02653092-gonadorelin-v1
- Content SHA-256: `7736bcfede5b57e445fac124e60c221cf172ca55f7b1e0469e16c0456ca103cc`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT02653092 ([`ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe`](#source-ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02653092 at 2026-11-16T17:31:07.936Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe`](#source-ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02653092 at 2026-11-16T17:31:07.936Z. Its registry update date was 2026-03-02, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe`](#source-ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe`](#source-ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe))

### Sources

<a id="source-ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe"></a>
- **ClinicalTrials.gov record NCT02653092 · retained source version 2026-03-02:9a6a3b14a3fe00d7e356b16b2f32f7cebe437bbd4348c9ff09408029a2644a35** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02653092) (`ctg-observation-nct02653092-2026-03-02-9a6a3b14a3fe`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02653092." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct02653092-gonadorelin-v1 SHA-256: 7736bcfede5b57e445fac124e60c221cf172ca55f7b1e0469e16c0456ca103cc.

---

<a id="clinicaltrials-gov-nct04037254-gonadorelin-v1"></a>

## ClinicalTrials.gov record NCT04037254

> PeptideScanner retained ClinicalTrials.gov record NCT04037254 at 2026-11-16T17:31:07.936Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was gonadorelin.

- Evidence object: `story:clinicaltrials-gov-nct04037254-gonadorelin:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-10
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04037254-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct04037254-gonadorelin-v1
- Content SHA-256: `601b1e1dab07d70e0e56fbc0b5acdd5d172fd214de06b2d6f1d16f0ff8de2ae7`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04037254 ([`ctg-observation-nct04037254-2026-07-10-e8230dbd403a`](#source-ctg-observation-nct04037254-2026-07-10-e8230dbd403a))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04037254 at 2026-11-16T17:31:07.936Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct04037254-2026-07-10-e8230dbd403a`](#source-ctg-observation-nct04037254-2026-07-10-e8230dbd403a))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04037254 at 2026-11-16T17:31:07.936Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was gonadorelin. ([`ctg-observation-nct04037254-2026-07-10-e8230dbd403a`](#source-ctg-observation-nct04037254-2026-07-10-e8230dbd403a))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04037254-2026-07-10-e8230dbd403a`](#source-ctg-observation-nct04037254-2026-07-10-e8230dbd403a))

### Sources

<a id="source-ctg-observation-nct04037254-2026-07-10-e8230dbd403a"></a>
- **ClinicalTrials.gov record NCT04037254 · retained source version 2026-07-10:e8230dbd403a71f7d569a0d14d403b99e89db24d3fb3dc2fc79d42497b930871** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04037254) (`ctg-observation-nct04037254-2026-07-10-e8230dbd403a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04037254." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#clinicaltrials-gov-nct04037254-gonadorelin-v1 SHA-256: 601b1e1dab07d70e0e56fbc0b5acdd5d172fd214de06b2d6f1d16f0ff8de2ae7.

---

<a id="fda-drugs-nda018123-v1"></a>

## Drugs@FDA application NDA018123

> The official Drugs@FDA dataset lists original submission 1 for NDA 018123 with status AP dated 1982-09-30, and names gonadorelin hydrochloride among the application record's active ingredients.

- Evidence object: `story:fda-drugs-nda018123:v1`
- Evidence domain: Regulatory
- Date in source: 1982-09-30
- Source checked: 2026-11-17
- Published by PeptideScanner: 2026-11-17
- Story landing page: https://peptidescanner.com/stories/fda-drugs-nda018123/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#fda-drugs-nda018123-v1
- Content SHA-256: `243c0b7441cbfbf57c9b7bfe19de36fae78930aa0b8b3780ce040dd2fe0a35b5`

### Claims and source pins

#### Headline

Drugs@FDA application NDA018123 ([`fda-drugs-nda018123-1982-09-30-d1e031a81303`](#source-fda-drugs-nda018123-1982-09-30-d1e031a81303))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for NDA 018123 with status AP dated 1982-09-30, and names gonadorelin hydrochloride among the application record's active ingredients. ([`fda-drugs-nda018123-1982-09-30-d1e031a81303`](#source-fda-drugs-nda018123-1982-09-30-d1e031a81303))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for NDA 018123 with status AP dated 1982-09-30, and names gonadorelin hydrochloride among the application record's active ingredients. ([`fda-drugs-nda018123-1982-09-30-d1e031a81303`](#source-fda-drugs-nda018123-1982-09-30-d1e031a81303))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-nda018123-1982-09-30-d1e031a81303`](#source-fda-drugs-nda018123-1982-09-30-d1e031a81303))

### Sources

<a id="source-fda-drugs-nda018123-1982-09-30-d1e031a81303"></a>
- **Drugs@FDA application NDA018123 · original submission status AP · 1982-09-30 · dataset 2026-11-16** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA018123%22&limit=1) (`fda-drugs-nda018123-1982-09-30-d1e031a81303`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application NDA018123." Version 1, published 2026-11-17. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#fda-drugs-nda018123-v1 SHA-256: 243c0b7441cbfbf57c9b7bfe19de36fae78930aa0b8b3780ce040dd2fe0a35b5.

---

<a id="pubmed-pmid-1980667-gonadorelin-v1"></a>

## Stability and purity profile of gonadorelin acetate: a high-purity gonadotropin-releasing hormone.

> PubMed lists PMID 1980667 in International journal of fertility as Journal Article, with publication-date metadata of 1990 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-1980667-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2006-11-15
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-1980667-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-1980667-gonadorelin-v1
- Content SHA-256: `c1af4a7d3aab7322e8841c643669731d59d642cf3a48eb673ab88c83357fe072`

### Claims and source pins

#### Headline

Stability and purity profile of gonadorelin acetate: a high-purity gonadotropin-releasing hormone. ([`pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378`](#source-pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378))

#### Summary

PubMed lists PMID 1980667 in International journal of fertility as Journal Article, with publication-date metadata of 1990 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378`](#source-pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378))

#### Paragraph 1

PubMed lists PMID 1980667 in International journal of fertility as Journal Article, with publication-date metadata of 1990 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378`](#source-pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378`](#source-pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378))

### Sources

<a id="source-pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378"></a>
- **Stability and purity profile of gonadorelin acetate: a high-purity gonadotropin-releasing hormone. · retained source version 1:2006-11-15:current:2e87abea7378194314319fa654a3750337616af61a9d866a7ef9417c0b4c9247** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/1980667/) (`pubmed-observation-pmid-1980667-2006-11-15-2e87abea7378`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Stability and purity profile of gonadorelin acetate: a high-purity gonadotropin-releasing hormone." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-1980667-gonadorelin-v1 SHA-256: c1af4a7d3aab7322e8841c643669731d59d642cf3a48eb673ab88c83357fe072.

---

<a id="pubmed-pmid-2885699-gonadorelin-v1"></a>

## \[Comparative clinico-therapeutic study of gonadorelin and chorionic gonadotropin in boys with undescended testes\].

> PubMed lists PMID 2885699 in Lijecnicki vjesnik as Clinical Trial, Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1987 Feb-Mar (source-text precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-2885699-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2009-11-11
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-2885699-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-2885699-gonadorelin-v1
- Content SHA-256: `1657814ae327d4bd6597a5b6838428c819fbcd7f13e6ee49e5374b9fb82cc49f`

### Claims and source pins

#### Headline

\[Comparative clinico-therapeutic study of gonadorelin and chorionic gonadotropin in boys with undescended testes\]. ([`pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c`](#source-pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c))

#### Summary

PubMed lists PMID 2885699 in Lijecnicki vjesnik as Clinical Trial, Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1987 Feb-Mar (source-text precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c`](#source-pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c))

#### Paragraph 1

PubMed lists PMID 2885699 in Lijecnicki vjesnik as Clinical Trial, Comparative Study, English Abstract, Journal Article, with publication-date metadata of 1987 Feb-Mar (source-text precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c`](#source-pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c`](#source-pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c))

### Sources

<a id="source-pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c"></a>
- **\[Comparative clinico-therapeutic study of gonadorelin and chorionic gonadotropin in boys with undescended testes\]. · retained source version 1:2009-11-11:current:98d0b939a25c6347cc32cc6f2d8512df2a52c9224569ae351aa8f892c458d9ae** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/2885699/) (`pubmed-observation-pmid-2885699-2009-11-11-98d0b939a25c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Comparative clinico-therapeutic study of gonadorelin and chorionic gonadotropin in boys with undescended testes\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-2885699-gonadorelin-v1 SHA-256: 1657814ae327d4bd6597a5b6838428c819fbcd7f13e6ee49e5374b9fb82cc49f.

---

<a id="pubmed-pmid-2940565-gonadorelin-v1"></a>

## \[Post-traumatic panhypopituitarism. Contribution of the gonadorelin pump to the topographic diagnosis\].

> PubMed lists PMID 2940565 in Presse medicale (Paris, France : 1983) as Case Reports, Letter, with publication-date metadata of 1986-05-10 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-2940565-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-12-09
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-2940565-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-2940565-gonadorelin-v1
- Content SHA-256: `ffaf9bd31a46ed4cd57a2409261f1b733e5ce200ffb02d08437b8c2d253795c3`

### Claims and source pins

#### Headline

\[Post-traumatic panhypopituitarism. Contribution of the gonadorelin pump to the topographic diagnosis\]. ([`pubmed-observation-pmid-2940565-2016-12-09-db700867af28`](#source-pubmed-observation-pmid-2940565-2016-12-09-db700867af28))

#### Summary

PubMed lists PMID 2940565 in Presse medicale (Paris, France : 1983) as Case Reports, Letter, with publication-date metadata of 1986-05-10 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-2940565-2016-12-09-db700867af28`](#source-pubmed-observation-pmid-2940565-2016-12-09-db700867af28))

#### Paragraph 1

PubMed lists PMID 2940565 in Presse medicale (Paris, France : 1983) as Case Reports, Letter, with publication-date metadata of 1986-05-10 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-2940565-2016-12-09-db700867af28`](#source-pubmed-observation-pmid-2940565-2016-12-09-db700867af28))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-2940565-2016-12-09-db700867af28`](#source-pubmed-observation-pmid-2940565-2016-12-09-db700867af28))

### Sources

<a id="source-pubmed-observation-pmid-2940565-2016-12-09-db700867af28"></a>
- **\[Post-traumatic panhypopituitarism. Contribution of the gonadorelin pump to the topographic diagnosis\]. · retained source version 1:2016-12-09:current:db700867af282ece576b260fc5dd51c95e15a3d497ac30b7420c7cf9b02c8655** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/2940565/) (`pubmed-observation-pmid-2940565-2016-12-09-db700867af28`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Post-traumatic panhypopituitarism. Contribution of the gonadorelin pump to the topographic diagnosis\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-2940565-gonadorelin-v1 SHA-256: ffaf9bd31a46ed4cd57a2409261f1b733e5ce200ffb02d08437b8c2d253795c3.

---

<a id="pubmed-pmid-30050082-gonadorelin-v1"></a>

## Zn2+-triggered self-assembly of Gonadorelin \[6-D-Phe\] to produce nanostructures and fibrils.

> PubMed lists PMID 30050082 in Scientific reports as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07-26 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30050082-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-10-22
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30050082-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-30050082-gonadorelin-v1
- Content SHA-256: `bfc876a8d11cd2ba3484fbe0777769a754eeab9fcfe18f4e4eb3ead22ed4a713`

### Claims and source pins

#### Headline

Zn2+-triggered self-assembly of Gonadorelin \[6-D-Phe\] to produce nanostructures and fibrils. ([`pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284`](#source-pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284))

#### Summary

PubMed lists PMID 30050082 in Scientific reports as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07-26 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284`](#source-pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284))

#### Paragraph 1

PubMed lists PMID 30050082 in Scientific reports as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2018-07-26 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284`](#source-pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284`](#source-pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284))

### Sources

<a id="source-pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284"></a>
- **Zn2+-triggered self-assembly of Gonadorelin \[6-D-Phe\] to produce nanostructures and fibrils. · retained source version 1:2019-10-22:current:3917f94eb284654dc9d0d17a1ae7669bdd4b106bcdcbbea8d03da495aaf2702e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30050082/) (`pubmed-observation-pmid-30050082-2019-10-22-3917f94eb284`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Zn2+-triggered self-assembly of Gonadorelin \[6-D-Phe\] to produce nanostructures and fibrils." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-30050082-gonadorelin-v1 SHA-256: bfc876a8d11cd2ba3484fbe0777769a754eeab9fcfe18f4e4eb3ead22ed4a713.

---

<a id="pubmed-pmid-31731249-gonadorelin-v1"></a>

## Reproductive performance of goats treated with free gonadorelin or nanoconjugated gonadorelin at estrus.

> PubMed lists PMID 31731249 in Domestic animal endocrinology as Journal Article, with publication-date metadata of 2019-09-06 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31731249-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-01-06
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31731249-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-31731249-gonadorelin-v1
- Content SHA-256: `681ac9f5a4286bc55d11f3b59f1c8c474f0d6efede329c787d841e177e686864`

### Claims and source pins

#### Headline

Reproductive performance of goats treated with free gonadorelin or nanoconjugated gonadorelin at estrus. ([`pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14`](#source-pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14))

#### Summary

PubMed lists PMID 31731249 in Domestic animal endocrinology as Journal Article, with publication-date metadata of 2019-09-06 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14`](#source-pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14))

#### Paragraph 1

PubMed lists PMID 31731249 in Domestic animal endocrinology as Journal Article, with publication-date metadata of 2019-09-06 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14`](#source-pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14`](#source-pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14))

### Sources

<a id="source-pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14"></a>
- **Reproductive performance of goats treated with free gonadorelin or nanoconjugated gonadorelin at estrus. · retained source version 1:2021-01-06:current:95ef4f129b1418c62b4bff0bb18c8f905a9fc66beb0496440e8c55c7471d0557** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31731249/) (`pubmed-observation-pmid-31731249-2021-01-06-95ef4f129b14`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Reproductive performance of goats treated with free gonadorelin or nanoconjugated gonadorelin at estrus." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-31731249-gonadorelin-v1 SHA-256: 681ac9f5a4286bc55d11f3b59f1c8c474f0d6efede329c787d841e177e686864.

---

<a id="pubmed-pmid-32599272-gonadorelin-v1"></a>

## Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin \[6-D-Phe\]: Production, optimization and in vitro release behavior.

> PubMed lists PMID 32599272 in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V as Journal Article, with publication-date metadata of 2020-06-27 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32599272-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-06-02
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32599272-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-32599272-gonadorelin-v1
- Content SHA-256: `1dad40b2d0703953c619e87d6b877193c7a9fe06b9ee15cf2da224e5d893a7d9`

### Claims and source pins

#### Headline

Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin \[6-D-Phe\]: Production, optimization and in vitro release behavior. ([`pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4`](#source-pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4))

#### Summary

PubMed lists PMID 32599272 in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V as Journal Article, with publication-date metadata of 2020-06-27 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4`](#source-pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4))

#### Paragraph 1

PubMed lists PMID 32599272 in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V as Journal Article, with publication-date metadata of 2020-06-27 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4`](#source-pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4`](#source-pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4))

### Sources

<a id="source-pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4"></a>
- **Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin \[6-D-Phe\]: Production, optimization and in vitro release behavior. · retained source version 1:2021-06-02:current:c4e9cc3496f4ebd91e39ead985cdbe25f71ed09d77b0eede285ad4b394e4eb8f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32599272/) (`pubmed-observation-pmid-32599272-2021-06-02-c4e9cc3496f4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Spray congealed solid lipid microparticles as a sustained release delivery system for Gonadorelin \[6-D-Phe\]: Production, optimization and in vitro release behavior." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-32599272-gonadorelin-v1 SHA-256: 1dad40b2d0703953c619e87d6b877193c7a9fe06b9ee15cf2da224e5d893a7d9.

---

<a id="pubmed-pmid-36858006-gonadorelin-v1"></a>

## Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin.

> PubMed lists PMID 36858006 in Journal of pharmaceutical and biomedical analysis as Case Reports, Journal Article, Review, with publication-date metadata of 2023-02-23 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36858006-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-03-31
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36858006-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-36858006-gonadorelin-v1
- Content SHA-256: `439587ac8dbcbf4f99fdd93a695bd554a7f3eaa94834dfe4bc7b1123e8c89d37`

### Claims and source pins

#### Headline

Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin. ([`pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d`](#source-pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d))

#### Summary

PubMed lists PMID 36858006 in Journal of pharmaceutical and biomedical analysis as Case Reports, Journal Article, Review, with publication-date metadata of 2023-02-23 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d`](#source-pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d))

#### Paragraph 1

PubMed lists PMID 36858006 in Journal of pharmaceutical and biomedical analysis as Case Reports, Journal Article, Review, with publication-date metadata of 2023-02-23 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d`](#source-pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d`](#source-pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d))

### Sources

<a id="source-pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d"></a>
- **Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin. · retained source version 1:2023-03-31:current:b7c860f5c58dad4d9afb58fd3b30d6d55fc5ecbe7c9ec2938d443ed83b157178** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36858006/) (`pubmed-observation-pmid-36858006-2023-03-31-b7c860f5c58d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Advances and perspectives in the analytical technology for small peptide hormones analysis: A glimpse to gonadorelin." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-36858006-gonadorelin-v1 SHA-256: 439587ac8dbcbf4f99fdd93a695bd554a7f3eaa94834dfe4bc7b1123e8c89d37.

---

<a id="pubmed-pmid-6150445-gonadorelin-v1"></a>

## \[Hormonal treatment of undescended testicles with gonadorelin (LH-RH)\].

> PubMed lists PMID 6150445 in Nederlands tijdschrift voor geneeskunde as Journal Article, with publication-date metadata of 1984-11-03 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-6150445-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2006-11-15
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-6150445-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6150445-gonadorelin-v1
- Content SHA-256: `9dbe379862000de05379880a445a3e1c25709467ae75f1daccc4a97f425b1476`

### Claims and source pins

#### Headline

\[Hormonal treatment of undescended testicles with gonadorelin (LH-RH)\]. ([`pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54`](#source-pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54))

#### Summary

PubMed lists PMID 6150445 in Nederlands tijdschrift voor geneeskunde as Journal Article, with publication-date metadata of 1984-11-03 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54`](#source-pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54))

#### Paragraph 1

PubMed lists PMID 6150445 in Nederlands tijdschrift voor geneeskunde as Journal Article, with publication-date metadata of 1984-11-03 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54`](#source-pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54`](#source-pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54))

### Sources

<a id="source-pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54"></a>
- **\[Hormonal treatment of undescended testicles with gonadorelin (LH-RH)\]. · retained source version 1:2006-11-15:current:511e2bde5f543723b6b53648cfdf330ca8fb4da33371391a7546ed818ee9d6f5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/6150445/) (`pubmed-observation-pmid-6150445-2006-11-15-511e2bde5f54`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Hormonal treatment of undescended testicles with gonadorelin (LH-RH)\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6150445-gonadorelin-v1 SHA-256: 9dbe379862000de05379880a445a3e1c25709467ae75f1daccc4a97f425b1476.

---

<a id="pubmed-pmid-6353073-gonadorelin-v1"></a>

## Biological assay of luteinizing hormone-releasing hormone (gonadorelin).

> PubMed lists PMID 6353073 in Journal of pharmacological methods as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1983-06 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-6353073-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-10-31
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-6353073-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6353073-gonadorelin-v1
- Content SHA-256: `6cd787e715b3e297bc84ea02fd21cd62baaa35254a189b90eb643234117a8a61`

### Claims and source pins

#### Headline

Biological assay of luteinizing hormone-releasing hormone (gonadorelin). ([`pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9`](#source-pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9))

#### Summary

PubMed lists PMID 6353073 in Journal of pharmacological methods as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1983-06 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9`](#source-pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9))

#### Paragraph 1

PubMed lists PMID 6353073 in Journal of pharmacological methods as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1983-06 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9`](#source-pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9`](#source-pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9))

### Sources

<a id="source-pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9"></a>
- **Biological assay of luteinizing hormone-releasing hormone (gonadorelin). · retained source version 1:2019-10-31:current:0124870f67b9cced2d15683aba090328566ba6a0c9a7daece9121b9574af8bae** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/6353073/) (`pubmed-observation-pmid-6353073-2019-10-31-0124870f67b9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Biological assay of luteinizing hormone-releasing hormone (gonadorelin)." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6353073-gonadorelin-v1 SHA-256: 6cd787e715b3e297bc84ea02fd21cd62baaa35254a189b90eb643234117a8a61.

---

<a id="pubmed-pmid-6358816-gonadorelin-v1"></a>

## Gonadorelin--synthetic LH-RH.

> PubMed lists PMID 6358816 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 1983-11-25 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-6358816-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2015-11-19
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-6358816-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6358816-gonadorelin-v1
- Content SHA-256: `bcc0a815188fd51d0938302b211c4ff866349d3adfe9eab40123ec53dd567ac6`

### Claims and source pins

#### Headline

Gonadorelin--synthetic LH-RH. ([`pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea`](#source-pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea))

#### Summary

PubMed lists PMID 6358816 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 1983-11-25 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea`](#source-pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea))

#### Paragraph 1

PubMed lists PMID 6358816 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 1983-11-25 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea`](#source-pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea`](#source-pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea))

### Sources

<a id="source-pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea"></a>
- **Gonadorelin--synthetic LH-RH. · retained source version 1:2015-11-19:current:bfc9d27b7dea26eea65848984771e153f9bd31a28565e9640e4a6c2eb1af20af** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/6358816/) (`pubmed-observation-pmid-6358816-2015-11-19-bfc9d27b7dea`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Gonadorelin--synthetic LH-RH." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6358816-gonadorelin-v1 SHA-256: bcc0a815188fd51d0938302b211c4ff866349d3adfe9eab40123ec53dd567ac6.

---

<a id="pubmed-pmid-6412255-gonadorelin-v1"></a>

## \[Capillary isotachophoresis--a new method in drug analysis. 1. Analytic capillary isotachophoresis of the peptide drugs saralasin, gonadorelin and protirelin\].

> PubMed lists PMID 6412255 in Die Pharmazie as English Abstract, Journal Article, with publication-date metadata of 1983-06 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-6412255-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2014-11-20
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-6412255-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6412255-gonadorelin-v1
- Content SHA-256: `295315c89788d72da1597002a64d96b02de2757aa44937ad7a3da6d24cb9197c`

### Claims and source pins

#### Headline

\[Capillary isotachophoresis--a new method in drug analysis. 1. Analytic capillary isotachophoresis of the peptide drugs saralasin, gonadorelin and protirelin\]. ([`pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33`](#source-pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33))

#### Summary

PubMed lists PMID 6412255 in Die Pharmazie as English Abstract, Journal Article, with publication-date metadata of 1983-06 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33`](#source-pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33))

#### Paragraph 1

PubMed lists PMID 6412255 in Die Pharmazie as English Abstract, Journal Article, with publication-date metadata of 1983-06 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33`](#source-pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33`](#source-pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33))

### Sources

<a id="source-pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33"></a>
- **\[Capillary isotachophoresis--a new method in drug analysis. 1. Analytic capillary isotachophoresis of the peptide drugs saralasin, gonadorelin and protirelin\]. · retained source version 1:2014-11-20:current:6c4be2d2cc33e35366465e279b8c9db6e57f56d66bbcb12f3ae6746926688c8c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/6412255/) (`pubmed-observation-pmid-6412255-2014-11-20-6c4be2d2cc33`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Capillary isotachophoresis--a new method in drug analysis. 1. Analytic capillary isotachophoresis of the peptide drugs saralasin, gonadorelin and protirelin\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6412255-gonadorelin-v1 SHA-256: 295315c89788d72da1597002a64d96b02de2757aa44937ad7a3da6d24cb9197c.

---

<a id="pubmed-pmid-6752326-gonadorelin-v1"></a>

## The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analy…

> PubMed lists PMID 6752326 in The Journal of endocrinology as Comparative Study, Journal Article, with publication-date metadata of 1982-10 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-6752326-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-07-09
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-6752326-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6752326-gonadorelin-v1
- Content SHA-256: `f41b09592529668b8608696f34208d6bfbb2427a2b583f94d19056176b1b69c3`

### Claims and source pins

#### Headline

The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analy… ([`pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb`](#source-pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb))

#### Summary

PubMed lists PMID 6752326 in The Journal of endocrinology as Comparative Study, Journal Article, with publication-date metadata of 1982-10 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb`](#source-pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb))

#### Paragraph 1

PubMed lists PMID 6752326 in The Journal of endocrinology as Comparative Study, Journal Article, with publication-date metadata of 1982-10 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb`](#source-pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb`](#source-pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb))

### Sources

<a id="source-pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb"></a>
- **The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analysis, different bioassays and immunoassay. · retained source version 1:2019-07-09:current:b42fb503fddb724d0147920982baf4ef5bbe21e44f36f07c887c692451532267** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/6752326/) (`pubmed-observation-pmid-6752326-2019-07-09-b42fb503fddb`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "The International Reference Preparation of Gonadorelin for Bioassay: a comparison with different preparations of synthetic luteinizing hormone releasing hormone using physicochemical methods of analy…." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-6752326-gonadorelin-v1 SHA-256: f41b09592529668b8608696f34208d6bfbb2427a2b583f94d19056176b1b69c3.

---

<a id="pubmed-pmid-7006547-gonadorelin-v1"></a>

## Gonadorelin and erythropoiesis.

> PubMed lists PMID 7006547 in Archives of internal medicine as Letter, with publication-date metadata of 1981-02 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-7006547-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2006-11-15
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-7006547-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-7006547-gonadorelin-v1
- Content SHA-256: `d9e85e9fdbf84ada755486a82756b7a2bc884a644e02f8bfe87678fa5b928a37`

### Claims and source pins

#### Headline

Gonadorelin and erythropoiesis. ([`pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063`](#source-pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063))

#### Summary

PubMed lists PMID 7006547 in Archives of internal medicine as Letter, with publication-date metadata of 1981-02 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063`](#source-pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063))

#### Paragraph 1

PubMed lists PMID 7006547 in Archives of internal medicine as Letter, with publication-date metadata of 1981-02 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063`](#source-pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063`](#source-pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063))

### Sources

<a id="source-pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063"></a>
- **Gonadorelin and erythropoiesis. · retained source version 1:2006-11-15:current:c9f7a56cb06396789a634b5e80c590d47dcd05be44345c6f6a4c707ebda29e4c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/7006547/) (`pubmed-observation-pmid-7006547-2006-11-15-c9f7a56cb063`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Gonadorelin and erythropoiesis." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-7006547-gonadorelin-v1 SHA-256: d9e85e9fdbf84ada755486a82756b7a2bc884a644e02f8bfe87678fa5b928a37.

---

<a id="pubmed-pmid-7576445-gonadorelin-v1"></a>

## Bioavailability of buserelin and gonadorelin in suspensions.

> PubMed lists PMID 7576445 in Bollettino chimico farmaceutico as Journal Article, with publication-date metadata of 1995-09 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-7576445-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-7576445-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-7576445-gonadorelin-v1
- Content SHA-256: `f27b6670d2463751edda566dc01dcc962d8c612fcc0106255ad41b4100dfc6a8`

### Claims and source pins

#### Headline

Bioavailability of buserelin and gonadorelin in suspensions. ([`pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc`](#source-pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc))

#### Summary

PubMed lists PMID 7576445 in Bollettino chimico farmaceutico as Journal Article, with publication-date metadata of 1995-09 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc`](#source-pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc))

#### Paragraph 1

PubMed lists PMID 7576445 in Bollettino chimico farmaceutico as Journal Article, with publication-date metadata of 1995-09 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc`](#source-pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc`](#source-pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc))

### Sources

<a id="source-pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc"></a>
- **Bioavailability of buserelin and gonadorelin in suspensions. · retained source version 1:2013-11-21:current:773a4734e3dcaef434abe6da6ad4d053837499a458d43971ad72e6736541d968** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/7576445/) (`pubmed-observation-pmid-7576445-2013-11-21-773a4734e3dc`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Bioavailability of buserelin and gonadorelin in suspensions." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-7576445-gonadorelin-v1 SHA-256: f27b6670d2463751edda566dc01dcc962d8c612fcc0106255ad41b4100dfc6a8.

---

<a id="pubmed-pmid-8491839-gonadorelin-v1"></a>

## Identification of gonadorelin (LHRH) derivatives: comparison of reversed-phase high-performance liquid chromatography and micellar electrokinetic chromatography.

> PubMed lists PMID 8491839 in Journal of chromatography as Comparative Study, Journal Article, with publication-date metadata of 1993-04-23 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-8491839-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-06-30
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-8491839-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-8491839-gonadorelin-v1
- Content SHA-256: `56c9fbbce8417380fd9ebe4191f7e5475391e35bbf56cecf3fe1d3305e6ab8f4`

### Claims and source pins

#### Headline

Identification of gonadorelin (LHRH) derivatives: comparison of reversed-phase high-performance liquid chromatography and micellar electrokinetic chromatography. ([`pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d`](#source-pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d))

#### Summary

PubMed lists PMID 8491839 in Journal of chromatography as Comparative Study, Journal Article, with publication-date metadata of 1993-04-23 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d`](#source-pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d))

#### Paragraph 1

PubMed lists PMID 8491839 in Journal of chromatography as Comparative Study, Journal Article, with publication-date metadata of 1993-04-23 (day precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d`](#source-pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d`](#source-pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d))

### Sources

<a id="source-pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d"></a>
- **Identification of gonadorelin (LHRH) derivatives: comparison of reversed-phase high-performance liquid chromatography and micellar electrokinetic chromatography. · retained source version 1:2019-06-30:current:6bd4f0b1475d56d95998e32246887659d2bf6e77a7e44cd7a759a3317cf2d577** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/8491839/) (`pubmed-observation-pmid-8491839-2019-06-30-6bd4f0b1475d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Identification of gonadorelin (LHRH) derivatives: comparison of reversed-phase high-performance liquid chromatography and micellar electrokinetic chromatography." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-8491839-gonadorelin-v1 SHA-256: 56c9fbbce8417380fd9ebe4191f7e5475391e35bbf56cecf3fe1d3305e6ab8f4.

---

<a id="pubmed-pmid-8897270-gonadorelin-v1"></a>

## Degradation kinetics of gonadorelin in aqueous solution.

> PubMed lists PMID 8897270 in Journal of pharmaceutical sciences as Journal Article, with publication-date metadata of 1996-10 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-8897270-gonadorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-8897270-gonadorelin/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-8897270-gonadorelin-v1
- Content SHA-256: `9ccc94f6063eeec179e6d7ba988089d3d5ffcccf9e2e5b7e93cb29ebe71589f1`

### Claims and source pins

#### Headline

Degradation kinetics of gonadorelin in aqueous solution. ([`pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663`](#source-pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663))

#### Summary

PubMed lists PMID 8897270 in Journal of pharmaceutical sciences as Journal Article, with publication-date metadata of 1996-10 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663`](#source-pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663))

#### Paragraph 1

PubMed lists PMID 8897270 in Journal of pharmaceutical sciences as Journal Article, with publication-date metadata of 1996-10 (month precision). PeptideScanner associated the retained record with the identity slug gonadorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663`](#source-pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663`](#source-pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663))

### Sources

<a id="source-pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663"></a>
- **Degradation kinetics of gonadorelin in aqueous solution. · retained source version 1:2013-11-21:current:774cfcb61663939497358a0bc3d7802623b8f50863f8949222d99e22e986efcc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/8897270/) (`pubmed-observation-pmid-8897270-2013-11-21-774cfcb61663`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Degradation kinetics of gonadorelin in aqueous solution." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/gonadorelin.json#pubmed-pmid-8897270-gonadorelin-v1 SHA-256: 9ccc94f6063eeec179e6d7ba988089d3d5ffcccf9e2e5b7e93cb29ebe71589f1.

